1 |
II collagen
(454 times)
|
Allergy and Immunology (172 times)
|
CIA (223 times) RA (127 times) IL (20 times)
|
1986 [Induction of arthritis in mice by injection of homologous type II collagen].
|
2 |
collagen type II
(116 times)
|
Allergy and Immunology (45 times)
|
RA (42 times) CIA (37 times) IL (11 times)
|
1986 Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats.
|
3 |
complex II
(48 times)
|
Biochemistry (8 times)
|
CI (18 times) ROS (13 times) SDH (6 times)
|
2007 Mitochondrial mechanism of neuroprotection by CART.
|
4 |
collagen II
(45 times)
|
Allergy and Immunology (16 times)
|
CIA (25 times) RA (17 times) TCR (5 times)
|
1989 Oestrogen-mediated suppression of collagen-induced arthritis in rats. Studies on the role of the thymus and of peripheral CD8+ T lymphocytes.
|
5 |
chicken type II collagen
(34 times)
|
Allergy and Immunology (15 times)
|
CIA (14 times) RA (10 times) WT (4 times)
|
1987 Attenuation of collagen arthritis and modulation of delayed-type hypersensitivity by type II collagen reactive T-cell lines.
|
6 |
Childhood Immunization Initiative
(25 times)
|
Public Health (24 times)
|
Hib (11 times) NIS (8 times) MMR (5 times)
|
1994 Vaccination coverage of 2-year-old children--United States, third quarter, 1993.
|
7 |
cognitive impairment index
(19 times)
|
Neurology (10 times)
|
SLE (5 times) MS (3 times) RRMS (3 times)
|
1999 Cognitive outcome after unilateral pallidal stimulation in Parkinson's disease.
|
8 |
continuous insulin infusion
(15 times)
|
Endocrinology (4 times)
|
ICU (4 times) BG (3 times) DKA (3 times)
|
1982 Continuous insulin infusion in hyperglycemic, very low birth weight infants.
|
9 |
continuous intravenous infusion
(15 times)
|
Endocrinology (3 times)
|
ICU (6 times) PCA (2 times) SCB (2 times)
|
2001 A safe and effective method for converting cancer patients from intravenous to transdermal fentanyl.
|
10 |
anti-collagen type II
(14 times)
|
Allergy and Immunology (9 times)
|
CIA (7 times) RA (6 times) TNF-alpha (2 times)
|
1994 Accelerated onset of collagen-induced arthritis by remote inflammation.
|
11 |
class II
(11 times)
|
Transplantation (2 times)
|
CI (8 times) sHSPs (2 times) WT (2 times)
|
2003 Purification and characterization of class-I and class-II fructose-1,6-bisphosphate aldolases from the cyanobacterium Synechocystis sp. PCC 6803.
|
12 |
type-II collagen
(11 times)
|
Allergy and Immunology (7 times)
|
CIA (4 times) RA (3 times) AC (1 time)
|
1993 Critical role of peripheral blood phagocytes and the involvement of complement in tumour necrosis factor enhancement of passive collagen-arthritis.
|
13 |
critical illness insurance
(10 times)
|
Health Services (4 times)
|
OOP (5 times) CHE (4 times) AG (1 time)
|
2011 Equitable access to healthcare services and income replacement for cancer: is critical illness insurance a help or a hindrance?
|
14 |
CIA was induced by immunization with type II collagen
(9 times)
|
Pharmacology (3 times)
|
CIA (9 times) IL (2 times) IL-1 (2 times)
|
1999 Enhancement of collagen-induced arthritis in mice by diesel exhaust particles.
|
15 |
correlation intensity index
(9 times)
|
Toxicology (5 times)
|
IIC (6 times) QSARs (2 times) DCW (1 time)
|
2020 Correlation intensity index: Building up models for mutagenicity of silver nanoparticles.
|
16 |
Contrast Improvement Index
(8 times)
|
Medical Informatics (6 times)
|
CLAHE (2 times) PSNR (2 times) AG (1 time)
|
2012 Comparing the performance of image enhancement methods to detect microcalcification clusters in digital mammography.
|
17 |
cultural importance index
(8 times)
|
Social Sciences (6 times)
|
FL (6 times) IAR (6 times) RFC (5 times)
|
2011 Documentation and quantitative analysis of the local knowledge on medicinal plants among traditional Siddha healers in Virudhunagar district of Tamil Nadu, India.
|
18 |
Chiari type II malformation
(7 times)
|
Neurology (7 times)
|
MRI (1 time) SP (1 time) VOR (1 time)
|
2005 Saccades in children with spina bifida and Chiari type II malformation.
|
19 |
chronic inflammatory infiltrate
(7 times)
|
Urologic Diseases (3 times)
|
PCa (6 times) PSA (4 times) PV (3 times)
|
1997 Cytotoxicity of Ketac Silver cement.
|
20 |
chicken collagen type II
(6 times)
|
Rheumatology (2 times)
|
CIA (5 times) RA (3 times) CAIA (1 time)
|
2008 Prophylactic but not therapeutic activity of a monoclonal antibody that neutralizes the binding of VEGF-B to VEGFR-1 in a murine collagen-induced arthritis model.
|
21 |
checkpoint inhibitor immunotherapy
(5 times)
|
Neoplasms (3 times)
|
cfmiR (2 times) miRs (2 times) NGS (2 times)
|
2019 Prospective Molecular Profiling of Circulating Tumor Cells from Patients with Melanoma Receiving Combinatorial Immunotherapy.
|
22 |
chronic intestinal ischemia
(5 times)
|
General Surgery (3 times)
|
SMA (3 times) CA (2 times) SBF (2 times)
|
2002 Endovascular treatment as first choice in chronic intestinal ischemia.
|
23 |
clinically important improvement
(5 times)
|
Rheumatology (3 times)
|
axSpA (2 times) MI (2 times) altASDAS (1 time)
|
2020 The impact of multijoint symptoms on patient-reported disability following surgery for lumbar spine osteoarthritis.
|
24 |
anti-collagen II
(4 times)
|
Pharmacology (2 times)
|
CIA (3 times) RA (3 times) CNBr (1 time)
|
1994 Meniere's disease: role of antibodies against basement membrane antigens.
|
25 |
cell responses to type II collagen
(4 times)
|
Rheumatology (3 times)
|
RA (4 times) CIA (2 times) anti-VEGF (1 time)
|
1997 T cell responses to human type II collagen in patients with rheumatoid arthritis and healthy controls.
|
26 |
chromosome II
(4 times)
|
Genetics (1 time)
|
C-I (2 times) MSHA (1 time) VPI-2 (1 time)
|
2006 Genome analyses of three strains of Rhodobacter sphaeroides: evidence of rapid evolution of chromosome II.
|
27 |
Composite Index of Impairments
(4 times)
|
Neurology (3 times)
|
---
|
1993 Epilepsy treatment in The Netherlands. Comparison of two medical centres.
|
28 |
COX-2 gene were immunized with type II collagen
(4 times)
|
Allergy and Immunology (3 times)
|
CIA (4 times) LPS (2 times) COX-1 (1 time)
|
2001 The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis.
|
29 |
Cancer Informatics Infrastructure
(3 times)
|
Medical Informatics (2 times)
|
CDEs (1 time) NCI (1 time)
|
1999 Role of clinical trials informatics in the NCI's cancer informatics infrastructure.
|
30 |
cartilage protein, collagen type II
(3 times)
|
Biochemistry (1 time)
|
CIA (2 times) RA (2 times) CTRL (1 time)
|
2009 Pathogenic antibody recognition of cartilage.
|
31 |
cartilage type II collagen
(3 times)
|
Rheumatology (1 time)
|
OA (2 times) ACAID (1 time) APCs (1 time)
|
2003 Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
|
32 |
cell determinant of type II collagen
(3 times)
|
Allergy and Immunology (2 times)
|
CIA (1 time) rCII (1 time)
|
1994 Characterization of the T cell determinants in the induction of autoimmune arthritis by bovine alpha 1(II)-CB11 in H-2q mice.
|
33 |
cell recognition of the type II collagen
(3 times)
|
Allergy and Immunology (3 times)
|
CIA (1 time)
|
1992 Identification of an immunodominant type-II collagen peptide recognized by T cells in H-2q mice: self tolerance at the level of determinant selection.
|
34 |
cellular type II collagen
(3 times)
|
Rheumatology (2 times)
|
RA (2 times) TNF-alpha (2 times) CIA (1 time)
|
2001 Genetic ablation of interferon-gamma up-regulates interleukin-1beta expression and enables the elicitation of collagen-induced arthritis in a nonsusceptible mouse strain.
|
35 |
chilling injury index
(3 times)
|
Plant Physiological Phenomena (2 times)
|
GWAS (1 time) PAL (1 time) POD (1 time)
|
2001 Effect of temperature on enzymatic and physiological factors related to chilling injury in carambola fruit (Averrhoa carambola L.).
|
36 |
class II collagenase
(3 times)
|
Transplantation (3 times)
|
CI (3 times) CDA (1 time) SDS-PAGE (1 time)
|
2007 Enhancing the success of human islet isolation through optimization and characterization of pancreas dissociation enzyme.
|
37 |
Colon Inflammatory Index
(3 times)
|
Neoplasms (2 times)
|
LDH (2 times) NLR (2 times) OS (2 times)
|
2019 Prognostic role of a new inflammatory index with neutrophil-to-lymphocyte ratio and lactate dehydrogenase (CII: Colon Inflammatory Index) in patients with metastatic colorectal cancer: results from the randomized Italian Trial in Advanced Colorectal Cancer(ITACa) study.
|
38 |
component II
(3 times)
|
Biochemistry (2 times)
|
CI (3 times) ESR (1 time) IEF (1 time)
|
1984 Bohr effect, electron spin resonance spectroscopy and subunit dissociation of the hemoglobin components from the turtle Phrynops hilarii.
|
39 |
computational integral imaging
(3 times)
|
Ophthalmology (3 times)
|
EIA (1 time) IBP (1 time) SR (1 time)
|
2007 Improved analysis on the signal property of computational integral imaging system.
|
40 |
continuous intravenous insulin infusions
(3 times)
|
Endocrinology (3 times)
|
CABG (2 times) BG (1 time) CBG (1 time)
|
2006 Clinical effects of hyperglycemia in the cardiac surgery population: the Portland Diabetic Project.
|
41 |
Critical Incident Inventory
(3 times)
|
Occupational Health (2 times)
|
---
|
2020 Prevalence of exposure to critical incidents in firefighters across Canada.
|
42 |
CAARS Infrequency Index
(2 times)
|
Psychology (1 time)
|
ADHD (2 times) CAARS (2 times) INC (1 time)
|
2017 Utility of the Conners' Adult ADHD Rating Scale validity scales in identifying simulated attention-deficit hyperactivity disorder and random responding.
|
43 |
Canine-Incisor Index
(2 times)
|
Dentistry (1 time)
|
c-CII (1 time) CCI (1 time)
|
2000 Reliability of a method for the localization of displaced maxillary canines using a single panoramic radiograph.
|
44 |
capable of altering the immune response to type II collagen
(2 times)
|
Rheumatology (1 time)
|
CIA (1 time) IL-4 (1 time)
|
2002 Peptide-induced suppression of collagen-induced arthritis in HLA-DR1 transgenic mice.
|
45 |
cartilage component type II collagen
(2 times)
|
Pharmacology (1 time)
|
LPS (2 times) CIA (1 time) IgG (1 time)
|
2000 The role of lipopolysaccharide injected systemically in the reactivation of collagen-induced arthritis in mice.
|
46 |
cartilage-specific type II collagen
(2 times)
|
Rheumatology (1 time)
|
MMPs (1 time) OA (1 time) RA (1 time)
|
1998 Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial.
|
47 |
caused by type II collagen
(2 times)
|
Allergy and Immunology (2 times)
|
CFA (2 times) iNOS (2 times) MIP (2 times)
|
2006 Glycogen synthase kinase-3beta inhibition attenuates the degree of arthritis caused by type II collagen in the mouse.
|
48 |
cell injury index
(2 times)
|
Pulmonary Medicine (1 time)
|
GPx (2 times) AM (1 time) BSO (1 time)
|
1992 In vitro effects of hyperoxia on alveolar type II pneumocytes: inhibition of glutathione synthesis increases hyperoxic cell injury.
|
49 |
cells specific for type II collagen
(2 times)
|
Rheumatology (1 time)
|
CIA (1 time) RP (1 time)
|
2002 Identification of type II collagen peptide 261-273-specific T cell clones in a patient with relapsing polychondritis.
|
50 |
cellulose II
(2 times)
|
Molecular Biology (1 time)
|
CI (2 times) CFs (1 time) CNC (1 time)
|
2018 Cellulose I and II nanocrystals produced by sulfuric acid hydrolysis of Tetra pak cellulose I.
|
51 |
central terminals of type II synaptic glomeruli
(2 times)
|
Neurology (1 time)
|
FRAP (2 times) TI (1 time)
|
1989 Postnatal maturation of primary afferent terminations in the substantia gelatinosa of the rat spinal cord. An electron microscopic study.
|
52 |
cerebral ischemia injury
(2 times)
|
Molecular Biology (1 time)
|
ER (1 time) HUVECs (1 time) I/R (1 time)
|
2019 Downregulation of microRNA‑451 improves cell migration, invasion and tube formation in hypoxia‑treated HUVECs by targeting MIF.
|
53 |
chronic intestinal inflammation
(2 times)
|
Rheumatology (1 time)
|
AF (1 time) AU (1 time) CD (1 time)
|
1995 Bowel inflammation in anterior uveitis and spondyloarthropathy.
|
54 |
CIA, type II collagen
(2 times)
|
Allergy and Immunology (2 times)
|
CIA (2 times) CFA (1 time) IFA (1 time)
|
2002 IL-4-deficient mice develop less acute but more chronic relapsing collagen-induced arthritis.
|
55 |
citrullinated type II collagen
(2 times)
|
Allergy and Immunology (2 times)
|
ACPAs (1 time) LC (1 time) NC1 (1 time)
|
2010 Antibodies to citrullinated proteins: molecular interactions and arthritogenicity.
|
56 |
clinical score, paw thickness, and type II collagen
(2 times)
|
Rheumatology (2 times)
|
CIA (2 times) CTLA-4 (1 time) CTLA4-Ig (1 time)
|
2000 Adenovirus-mediated gene transfer of CTLA-4Ig fusion protein in the suppression of experimental autoimmune arthritis.
|
57 |
Cluster II
(2 times)
|
Allergy and Immunology (1 time)
|
CI (1 time) CIN (1 time) HSS1 and 2 (1 time)
|
2002 Variegated expression of CD8 alpha resulting from in situ deletion of regulatory sequences.
|
58 |
complex I and II
(2 times)
|
Biological Science Disciplines (1 time)
|
CHD (1 time) CI (1 time) ETS (1 time)
|
2013 Substrate-specific impairment of mitochondrial respiration in permeabilized fibers from patients with coronary heart disease versus valvular disease.
|
59 |
concentrations and type II collagen
(2 times)
|
Rheumatology (1 time)
|
RA (2 times) AA (1 time) CIA (1 time)
|
2005 Association of articular cartilage degradation and loss of boundary-lubricating ability of synovial fluid following injury and inflammatory arthritis.
|
60 |
Concept II
(2 times)
|
Sports Medicine (1 time)
|
WB (1 time)
|
1995 An evaluation of instrumented tank rowing for objective assessment of rowing performance.
|
61 |
confidence intervals
(2 times)
|
General Surgery (1 time)
|
BUN (1 time) eRVF (1 time) HRT (1 time)
|
1998 Randomized comparison of oral and transdermal hormone replacement on carotid and uterine artery resistance to blood flow.
|
62 |
content of anti-type II collagen
(2 times)
|
Therapeutics (1 time)
|
CCII (1 time) CIA (1 time) FcRbeta (1 time)
|
2012 Fc receptor beta chain deficiency exacerbates murine arthritis in the anti-type II collagen antibody-induced experimental model.
|
63 |
Continuous Innovation Indicators
(2 times)
|
Pharmaceutical Preparations (1 time)
|
FDA (1 time) OS (1 time)
|
2017 Approving cancer treatments based on endpoints other than overall survival: an analysis of historical data using the PACE Continuous Innovation Indicators™ (CII).
|
64 |
contribution of type II collagen
(2 times)
|
Rheumatology (2 times)
|
RA (2 times) CIA (1 time) CTGF (1 time)
|
1992 Interactions of synovial fluid immunoglobulins with chondrocytes.
|
65 |
cumulative intervention intensity
(2 times)
|
Rehabilitation (2 times)
|
FITT (1 time) MDAF (1 time) VERSE (1 time)
|
2020 An exploration of aphasia therapy dosage in the first six months of stroke recovery.
|
66 |
2-(p-hydroxyanilino)-4-(p-chlorophenyl) thiazole
(1 time)
|
Pulmonary Medicine (1 time)
|
ECs (1 time) PTX (1 time) S1P (1 time)
|
2011 Photolysis of caged sphingosine-1-phosphate induces barrier enhancement and intracellular activation of lung endothelial cell signaling pathways.
|
67 |
alpha-chain of human type II collagen
(1 time)
|
Allergy and Immunology (1 time)
|
---
|
1996 Characterization of the antigenic structure of human type II collagen.
|
68 |
c mice by been subcutaneously injected type II bovine collagen
(1 time)
|
Pharmacology (1 time)
|
ARCF (1 time) EE (1 time) IL-1beta (1 time)
|
2010 Extracts of Arisaema rhizomatum C.E.C. Fischer attenuate inflammatory response on collagen-induced arthritis in BALB/c mice.
|
69 |
c mice by two intradermal injections of type II collagen
(1 time)
|
Cells (1 time)
|
ANA (1 time) CIA (1 time) COMP (1 time)
|
2019 Combination Therapy of Mesenchymal Stromal Cells and Interleukin-4 Attenuates Rheumatoid Arthritis in a Collagen-Induced Murine Model.
|
70 |
C-terminal domain
(1 time)
|
Science (1 time)
|
---
|
2018 Molecular dynamics simulations of nucleotide release from the circadian clock protein KaiC reveal atomic-resolution functional insights.
|
71 |
Calcipex II
(1 time)
|
Dentistry (1 time)
|
CP (1 time) CZ (1 time) FT-Raman (1 time)
|
2017 Molecular and morphological surface analysis: effect of filling pastes and cleaning agents on root dentin.
|
72 |
calcitonin treatment influences the increases in type II collagen
(1 time)
|
Rheumatology (1 time)
|
---
|
2007 The effect of oral calcitonin on cartilage turnover and surface erosion in an ovariectomized rat model.
|
73 |
can be suppressed by intravenous injection of native type II
(1 time)
|
Allergy and Immunology (1 time)
|
CB (1 time)
|
1989 Identification of an immunosuppressive epitope of type II collagen that confers protection against collagen-induced arthritis.
|
74 |
can present DR4-restricted type II collagen
(1 time)
|
Rheumatology (1 time)
|
CIA (1 time) RA (1 time)
|
2006 New humanized HLA-DR4-transgenic mice that mimic the sex bias of rheumatoid arthritis.
|
75 |
can react identically with a single epitope on one antigen
(1 time)
|
Allergy and Immunology (1 time)
|
mAb (1 time)
|
2004 Two monoclonal antibodies to precisely the same epitope of type II collagen select non-crossreactive phage clones by phage display: implications for autoimmunity and molecular mimicry.
|
76 |
can recognize peptide antigens derived from type-II collagen
(1 time)
|
Biochemistry (1 time)
|
CIA (1 time)
|
2016 Induction of tolerance against the arthritogenic antigen with type-II collagen peptide-linked soluble MHC class II molecules.
|
77 |
can render oral tolerance to type II collagen
(1 time)
|
Rheumatology (1 time)
|
CIA (1 time) TGF-beta (1 time)
|
1999 Modulation by cytokines of induction of oral tolerance to type II collagen.
|
78 |
can suppress the development and progression of type II collagen
(1 time)
|
Medicine (1 time)
|
HFLS (1 time) PKD1 (1 time) TLR (1 time)
|
2019 Ameliorating effects of Go6976, a pharmacological agent that inhibits protein kinase D, on collagen-induced arthritis.
|
79 |
candidate autoantigen type II collagen
(1 time)
|
Allergy and Immunology (1 time)
|
CIA (1 time) DR4 (1 time) RA (1 time)
|
2002 The influence of HLA-DR4 (0401) on the immune response to type II collagen and the development of collagen induced arthritis in mice.
|
80 |
capable of producing antibodies reactive to type II collagen
(1 time)
|
Rheumatology (1 time)
|
Ig (1 time) PB (1 time) RA (1 time)
|
2001 Anti-Human type II collagen CD19+ B cells are present in patients with rheumatoid arthritis and healthy individuals.
|
81 |
carbon intensity indicator
(1 time)
|
Environmental Health (1 time)
|
EEXI (1 time) IMO (1 time) TEU (1 time)
|
2023 Environmental economic analysis of speed reduction measure onboard container ships.
|
82 |
carbon ion implantation
(1 time)
|
Nanotechnology (1 time)
|
CoCrMo (1 time) MoM (1 time)
|
2017 Effect of carbon ion implantation on the tribology of metal-on-metal bearings for artificial joints.
|
83 |
carbon ion irradiation
(1 time)
|
Neoplasms (1 time)
|
DNP (1 time) GLUT1 (1 time) HKII (1 time)
|
2023 Enhanced Glycolysis Confers Resistance Against Photon but Not Carbon Ion Irradiation in Human Glioma Cell Lines.
|
84 |
carcinoma were injected with Type II collagen
(1 time)
|
Neoplasms (1 time)
|
AA (1 time) GF-II (1 time) IL-17 (1 time)
|
2011 Collagen induced arthritis increases secondary metastasis in MMTV-PyV MT mouse model of mammary cancer.
|
85 |
carrier-induced interlayer
(1 time)
|
Biomedical Engineering (1 time)
|
a-IGZO TFTs (1 time) VGO (1 time)
|
2021 Vertically Graded Oxygen Deficiency for Improving Electrical Characteristics and Stability of Indium Gallium Zinc Oxide Thin-Film Transistors.
|
86 |
cartilage damage; furthermore, the production of type II collagen
(1 time)
|
Rheumatology (1 time)
|
CAIA (1 time) CIA (1 time) FcgammaRIIb (1 time)
|
2010 The adaptor protein CIKS/ACT1 is necessary for collagen-induced arthritis, and it contributes to the production of collagen-specific antibody.
|
87 |
cartilage degradation through type II collagen
(1 time)
|
Rheumatology (1 time)
|
HNE (1 time) MMP-13 (1 time) OA (1 time)
|
2005 Production of lipid peroxidation products in osteoarthritic tissues: new evidence linking 4-hydroxynonenal to cartilage degradation.
|
88 |
cartilage derived molecule type II collagen
(1 time)
|
Rheumatology (1 time)
|
RA (1 time) SLE (1 time)
|
1995 Local versus systemic immunoreactivity to collagen and the collage-like region of C1q in rheumatoid arthritis and SLE.
|
89 |
cartilage destruction and significantly reduced pathogenic anti-type II collagen
(1 time)
|
Allergy and Immunology (1 time)
|
BiP (1 time) ELISA (1 time) IFN (1 time)
|
2014 Systemic gene transfer of binding immunoglobulin protein (BiP) prevents disease progression in murine collagen-induced arthritis.
|
90 |
cartilage include type II collagen
(1 time)
|
Allergy and Immunology (1 time)
|
DC (1 time)
|
2002 Differential MHC class II-mediated presentation of rheumatoid arthritis autoantigens by human dendritic cells and macrophages.
|
91 |
cartilage matrix macromolecules including type II collagen
(1 time)
|
Orthopedics (1 time)
|
BMI (1 time) CE (1 time) HNS (1 time)
|
2006 Differences in biomarkers of type II collagen in atrophic and hypertrophic osteoarthritis of the hip: implications for the differing pathobiologies.
|
92 |
cartilage proteins, proteoglycans, and type II collagen
(1 time)
|
Biochemistry (1 time)
|
EA (1 time) MMPs (1 time) PA (1 time)
|
2013 Inhibitory effects of polyphenol punicalagin on type-II collagen degradation in vitro and inflammation in vivo.
|
93 |
Cartilage was analyzed for type II collagen
(1 time)
|
Rheumatology (1 time)
|
CPII (1 time)
|
2006 Collagen and proteoglycan turnover in focally damaged human ankle cartilage: evidence for a generalized response and active matrix remodeling across the entire joint surface.
|
94 |
cartilage-specific proteins type II collagen
(1 time)
|
Rheumatology (1 time)
|
CXI (1 time) MHC (1 time) PIA (1 time)
|
2012 Class II major histocompatibility complex-associated response to type XI collagen regulates the development of chronic arthritis in rats.
|
95 |
casei administration reduced type II collagen
(1 time)
|
Allergy and Immunology (1 time)
|
CIA (1 time) L. casei (1 time) RA (1 time)
|
2008 Lactobacillus casei suppresses experimental arthritis by down-regulating T helper 1 effector functions.
|
96 |
casei alone or together with type II collagen
(1 time)
|
Biochemistry (1 time)
|
GLN (1 time) IFN-gamma (1 time) IL-1beta (1 time)
|
2010 Lactobacillus casei enhances type II collagen/glucosamine-mediated suppression of inflammatory responses in experimental osteoarthritis.
|
97 |
casein II
(1 time)
|
Physiology (1 time)
|
CI (1 time)
|
1981 Absorption of amino acids in different parts of the small intestine in growing pigs. III. Absorption of constituents of protein hydrolysates.
|
98 |
cases in the insular portion of the ipsilateral claustrum
(1 time)
|
Neurology (1 time)
|
FB (1 time) NY (1 time)
|
1983 Claustroneocortical projections studied in the cat by means of multiple retrograde fluorescent tracing.
|
99 |
casiopeina II (Cu(4,7-dimethyl-1,10-phenanthroline)(glycine)NO3)
(1 time)
|
Toxicology (1 time)
|
Hb (1 time) PCV (1 time) RBC (1 time)
|
2003 Hematotoxicity response in rats by the novel copper-based anticancer agent: casiopeina II.
|
100 |
category II
(1 time)
|
Diabetes Mellitus (1 time)
|
CI (1 time) CIII (1 time) CKD (1 time)
|
2014 Renal histological heterogeneity and functional progress in normoalbuminuric and microalbuminuric Japanese patients with type 2 diabetes.
|